244 related articles for article (PubMed ID: 22340345)
1. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
2. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
3. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
5. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy.
Meschi M; Detrenis S; Musini S; Strada E; Savazzi G
Crit Care Med; 2006 Aug; 34(8):2060-8. PubMed ID: 16763513
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
[TBL] [Abstract][Full Text] [Related]
7. [Contrast-induced nephropathy].
Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
[TBL] [Abstract][Full Text] [Related]
8. Recent issues in contrast-induced nephropathy.
Kitajima K; Maeda T; Watanabe S; Sugimura K
Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
[TBL] [Abstract][Full Text] [Related]
9. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
[TBL] [Abstract][Full Text] [Related]
10. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
13. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
14. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
15. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
16. Current concepts of contrast-induced nephropathy: a brief review.
Chang CF; Lin CC
J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
McCullough P
Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
[TBL] [Abstract][Full Text] [Related]
18. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches].
Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI
Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198
[TBL] [Abstract][Full Text] [Related]
19. Prevention of contrast-induced nephropathy: an overview.
Ellis JH; Cohan RH
Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
[TBL] [Abstract][Full Text] [Related]
20. [Contrast substances-induced nephropathy].
Mironova OIu
Ter Arkh; 2013; 85(6):90-5. PubMed ID: 23875199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
